Antiphospholipid syndrome, Lancet, vol.376, pp.1498-509, 2010. ,
Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons, Autoimmun Rev, vol.7, pp.262-268, 2008. ,
Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome, Rheumatology (Oxford), vol.46, pp.907-917, 2007. ,
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients, Ann Rheum Dis, vol.68, pp.1428-1460, 2009. ,
Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome, JAMA, vol.302, pp.1210-1217, 2009. ,
Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome, Clin Rev Allergy Immunol, vol.37, pp.29-35, 2009. ,
Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding, Semin Arthritis Rheum, vol.37, pp.373-80, 2008. ,
Patients with antiphospholipid syndrome display endothelial perturbation, J Autoimmun, vol.34, pp.105-115, 2010. ,
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo, Circulation, vol.99, pp.1997-2002, 1999. ,
Anti-?2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor ? and tissue factor by signal transduction pathways involving lipid rafts, Arthritis Rheum, vol.56, pp.2687-97, 2007. ,
Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome, Int Immunol, vol.17, pp.489-500, 2005. ,
The role of Toll-like receptors in chronic inflammation, Int J Biochem Cell Biol, vol.42, pp.506-524, 2010. ,
Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice, Crit Care Med, vol.37, pp.1724-1732, 2009. ,
Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction, Arterioscler Thromb Vasc Biol, vol.27, pp.1064-71, 2007. ,
Injury primes the innate immune system for enhanced Toll-like receptor reactivity, J Immunol, vol.171, pp.1473-83, 2003. ,
A novel pathway for human endothelial cell activation by antiphospholipid/anti-?2 glycoprotein I antibodies, Blood, vol.119, pp.884-93, 2011. ,
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies, Blood, vol.117, pp.5523-5554, 2011. ,
Anti-?2GPI/?2GPI induced TF and TNF-? expression in monocytes involving both TLR-4/MyD88 and TLR-4/TRIF signaling pathways, Mol Immunol, vol.53, pp.246-54, 2013. ,
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies, Blood, vol.101, pp.3495-500, 2003. ,
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies, Ann Rheum Dis, vol.66, pp.1327-1360, 2007. ,
Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine, Am J Transplant, vol.11, pp.2414-2436, 2011. ,
Hypertrophic remodeling and increased arterial stiffness in patients with intracranial aneurysms, Atherosclerosis, vol.211, pp.486-91, 2012. ,
Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension, Circulation, vol.125, pp.1266-75, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00680446
Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects, Diabetes Care, vol.33, pp.861-869, 2010. ,
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, pp.1059-69, 2011. ,
Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis Rheum, vol.63, pp.1961-71, 2011. ,
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?, Lupus, vol.17, pp.185-94, 2008. ,
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS, Autoimmun Rev, vol.11, pp.577-80, 2012. ,
Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome, Int J Clin Pract, vol.58, pp.1003-1010, 2004. ,
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function, Thromb Res, vol.123, pp.444-51, 2009. ,
Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies, Lupus, vol.14, pp.129-165, 2005. ,
Increased level of tumor necrosis factor-? in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state, Rheumatol Int, vol.31, pp.307-320, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00568320
Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep, Blood, vol.104, pp.2353-2361, 2004. ,
Enhanced monocyte expression of tissue factor by oxidative ROLE OF ,
, stress in patients with antiphospholipid antibodies: effect of antioxidant treatment, J Thromb Haemost, vol.1, pp.523-554, 2003.
Oxidative stress in primary antiphospholipid syndrome, Thromb Haemost, vol.79, pp.447-456, 1998. ,
Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model, Rheumatology (Oxford), vol.44, pp.1238-1282, 2005. ,
Antiphospholipid antibodies promote leukocyteendothelial cell adhesion and thrombosis in mice by antagonizing eNOS via ?2GPI and apoER2, J Clin Invest, vol.121, pp.120-151, 2011. ,
Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome, J Rheumatol, vol.37, pp.2523-2553, 2010. ,
Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4, Arterioscler Thromb Vasc Biol, vol.33, pp.777-84, 2013. ,
In vivo effects of an inhibitor of nuclear factor-B on thrombogenic properties of antiphospholipid antibodies, Ann N Y Acad Sci, vol.1108, pp.540-53, 2007. ,
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-?2 glycoprotein I antibodies, Blood, vol.105, pp.1964-1973, 2005. ,
Activation of MAPKs in the anti-?2GPI/?2GPI-induced tissue factor expression through TLR-4/IRAKs pathway in THP-1 cells, Thromb Res, vol.130, pp.229-264, 2012. ,
Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells, Cell Immunol, vol.276, pp.114-135, 2012. ,
NF-Bdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci, vol.103, pp.12481-12487, 2006. ,
TLR-4 signaling induces TLR-2 expression in endothelial cells via neutrophil NADPH oxidase, J Clin Invest, vol.112, pp.1234-1277, 2003. ,
Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gramnegative and gram-positive bacteria, Eur J Immunol, vol.33, pp.1127-1165, 2003. ,
A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome, PLoS One, vol.7, p.42176, 2012. ,
?2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model, Blood, vol.117, pp.3453-3462, 2011. ,
Infectious origin of the antiphospholipid syndrome, Ann Rheum Dis, vol.65, pp.2-6, 2006. ,
The role of TLR-4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity, Br J Haematol, vol.164, pp.165-76, 2014. ,